DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Australia
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
HXL logo

Hexima Limited Stock Price

ASX:HXL Community·AU$2.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

HXL Share Price Performance

AU$0
0.00 (0.00%)
​
AU$0
0.00 (0.00%)
​
Price AU$0
Sat, 12 Sep 26
Share Pricen/a

HXL Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet low.

3 Risks
1 Reward
View Full Analysis

Hexima Limited Key Details

AU$61.7k

Revenue

AU$0

Cost of Revenue

AU$61.7k

Gross Profit

AU$995.5k

Other Expenses

-AU$933.9k

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-0.0056
100.00%
-1,514.21%
0%
View Full Analysis

About HXL

Founded
1997
Employees
n/a
CEO
Geoffrey Kempler
WebsiteView website
hexima.com.au

Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company’s assets. Previously, the company was involved in the research and development of pezadeftide for the treatment of onychomycosis. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.

Recent HXL News & Updates

Recent updates

No updates

Hexima Limited Competitors

ZLD logo

Zelira Therapeutics

Symbol: ASX:ZLD
Market cap: AU$5.9m
BIT logo

Biotron

Symbol: ASX:BIT
Market cap: AU$5.6m
IVX logo

Invion

Symbol: ASX:IVX
Market cap: AU$4.9m
GTG logo

Genetic Technologies

Symbol: ASX:GTG
Market cap: AU$5.7m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide